Retina Health Center

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Macular degeneration

Closed trials

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source